{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:21:46Z","timestamp":1785378106241,"version":"3.55.0"},"reference-count":152,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012744","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T17:16:49Z","timestamp":1501521409000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy"],"prefix":"10.1002","volume":"2017","author":[{"given":"Philip","family":"Riley","sequence":"first","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Glenny","sequence":"additional","affiliation":[{"name":"The University of Manchester; Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hua","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V","family":"Worthington","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"10.1002\/14651858.CD012744-BIB0001|cit1","unstructured":"Abacioglu MU Effect of Pilocarpine for the Prevention of Radiation-Induced Xerostomia [Dissertation] Marmara (Turkey): Marmara University Hospital, 1997"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2009.25.5638","article-title":"Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial","volume":"29","author":"Bardet","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"6 Suppl 19","key":"10.1002\/14651858.CD012744-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/sonc.2002.37348","article-title":"Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy","volume":"29","author":"Bardet","year":"2002","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0005|cit5","unstructured":"Brizel D Sauer R Wannenmacher M Henke M Eschwege F Wasserman T Randomized phase III trial of radiation amifostine in patients with head and neck cancer 34th Annual Meeting of the American Society of Clinical Oncology; 1998 May 17-19; Los Angeles (USA) Los Angeles (USA) American Society of Clinical Oncology 1998"},{"issue":"14 Suppl","key":"10.1002\/14651858.CD012744-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1200\/jco.2004.22.90140.5536","article-title":"The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer: two year follow-up of a prospective randomized trial","volume":"22","author":"Brizel","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1002\/14651858.CD012744-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0360-3016(00)00768-9","article-title":"Protective effect of amifostine on dental health after radiotherapy of the head and neck","volume":"48","author":"Rudat","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD012744-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000061305","article-title":"Radioprotection of head and neck tissue by amifostine","volume":"37","author":"Strnad","year":"2002","journal-title":"Frontiers of Radiation Therapy and Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0360-3016(00)00735-5","article-title":"Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer","volume":"48","author":"Wasserman","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2005.07.966","article-title":"Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial","volume":"63","author":"Wasserman","year":"2005","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"15","key":"10.1002\/14651858.CD012744-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1200\/JCO.2007.13.7349","article-title":"Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma","volume":"26","author":"Brizel","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2005.08.005","article-title":"Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study","volume":"64","author":"Buentzel","year":"2006","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0020|cit14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/CNV-100000145","article-title":"Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany","volume":"19","author":"Bennett","year":"2001","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD012744-BIB0021|cit15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000312947","article-title":"Selective cytoprotection with amifostine: a new strategy in supportive care of head and neck malignancies","volume":"7","author":"Buntzel","year":"1997","journal-title":"Oto-Rhino-Laryngologia Nova"},{"key":"10.1002\/14651858.CD012744-BIB0022|cit16","doi-asserted-by":"crossref","unstructured":"Buntzel J Kuttner K Russell L Oster W Schuth J Glatzel M Selective cytoprotection by amifostine (A) in the treatment of head and neck cancer with simultaneous radiochemotherapy (RCT) European Cancer Conference; 1997 Sep 14-18; Hamburg (Germany) Hamburg (Germany) ECCO 1997","DOI":"10.1016\/S0959-8049(97)85527-X"},{"key":"10.1002\/14651858.CD012744-BIB0023|cit17","first-page":"393","article-title":"Selective cytoprotection by amifostine in the treatment of head and neck cancer with simultaneous radiochemotherapy","volume":"16","author":"Buntzel","year":"1997","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0019|cit18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03042192","article-title":"Experiences with selenium in the treatment of acute and late toxicities due to radiochemotherapy of head and neck cancer","volume":"94 Suppl III","author":"B\u00fcntzel","year":"1999","journal-title":"Medizinische Klinik"},{"issue":"81","key":"10.1002\/14651858.CD012744-BIB0014|cit19","first-page":"381","article-title":"Selective cytoprotection with amifostine in simultaneous radiochemotherapy of head neck cancer","volume":"7","author":"B\u00fcntzel","year":"1996","journal-title":"Annals of Oncology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012744-BIB0015|cit20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/srao.2002.31356","article-title":"Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer","volume":"12","author":"B\u00fcntzel","year":"2002","journal-title":"Seminars in Radiation Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0017|cit21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000312927","article-title":"Amifostine in simultaneous radiochemotherapy for head and neck cancer","volume":"7","author":"B\u00fcntzel","year":"1997","journal-title":"Oto-Rhino-Laryngologia Nova"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0016|cit22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1008282412670","article-title":"Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer","volume":"9","author":"B\u00fcntzel","year":"1998","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0018|cit23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s005200050150","article-title":"Radiochemotherapy with amifostine cytoprotection for head and neck cancer","volume":"6","author":"B\u00fcntzel","year":"1998","journal-title":"Supportive Care in Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD012744-BIB0026|cit24","doi-asserted-by":"crossref","first-page":"e20698","DOI":"10.1200\/jco.2009.27.15_suppl.e20698","article-title":"Evaluation of the effect of selenium on radiation-induced toxicities in head neck cancer patients","volume":"27","author":"Buentzel","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0024|cit25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/TEP27235","article-title":"Selenium substitution during radiotherapy in head and neck cancer","volume":"27","author":"B\u00fcntzel","year":"2010","journal-title":"Trace Elements and Electrolytes"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0025|cit26","first-page":"1829","article-title":"Limited effects of selenium substitution in the prevention of radiation-associated toxicities. Results of a randomized study in head and neck cancer patients","volume":"30","author":"B\u00fcntzel","year":"2010","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2007.06.016","article-title":"Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study","volume":"70","author":"Burlage","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hed.20162","article-title":"Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis","volume":"27","author":"Duncan","year":"2005","journal-title":"Head & Neck"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0360-3016(03)00121-4","article-title":"Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09","volume":"56","author":"Fisher","year":"2003","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0030|cit30","first-page":"252","article-title":"Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients","volume":"4","author":"Scarantino","year":"2006","journal-title":"Journal of Supportive Oncology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012744-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0360-3016(01)01981-2","article-title":"A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09","volume":"51","author":"Scarantino","year":"2001","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD012744-BIB0032|cit32","first-page":"225a","article-title":"A phase III study of concomitant oral pilocarpine to reduce hypo-salivation and mucositis associated with curative radiation therapy (RT) in head and neck (H&N) cancer patients. RTOG 9709","volume":"20","author":"Scarantino","year":"2001","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tripleo.2004.04.009","article-title":"Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer","volume":"98","author":"Gornitsky","year":"2004","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0034|cit34","first-page":"193","article-title":"Prophylaxis of mucositis and dry mouth after head and neck radiotherapy. A new treatment","volume":"23","author":"Gr\u00f6tz","year":"2002","journal-title":"Krankenhauspharmazie"},{"issue":"8","key":"10.1002\/14651858.CD012744-BIB0035|cit35","first-page":"397","article-title":"Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin\/Troxerutine in patients with head and neck cancer","volume":"175","author":"Gr\u00f6tz","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1054\/bjom.2000.0459","article-title":"Prophylaxis of radiogenic sialadenitis and mucositis by coumarin\/troxerutine in patients with head and neck cancer - a prospective, randomized, placebo-controlled, double-blind study","volume":"39","author":"Gr\u00f6tz","year":"2001","journal-title":"British Journal of Oral and Maxillofacial Surgery"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-8140(02)00104-4","article-title":"A randomised, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia","volume":"64","author":"Haddad","year":"2002","journal-title":"Radiotherapy and Oncology"},{"issue":"19","key":"10.1002\/14651858.CD012744-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1002\/cncr.24525","article-title":"Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin\/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer","volume":"115","author":"Haddad","year":"2009","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012744-BIB0039|cit39","first-page":"138","article-title":"Effects of concurrent chemoradiotherapy combined with Jinlong capsules for patients with advanced nasopharyngeal squamous carcinoma","volume":"(2)","author":"Han","year":"2010","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0040|cit40","first-page":"53","article-title":"Radioprotective effect of amifostine in nasopharyngeal carcinoma","volume":"31","author":"He","year":"2004","journal-title":"Fudan University Journal of Medical Sciences"},{"issue":"20","key":"10.1002\/14651858.CD012744-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012744-BIB0042|cit42","first-page":"623","article-title":"Clinical observation on effect of shenqi fanghou recipe in preventing and treating radiation injury in patients with head and neck tumour","volume":"25","author":"Hu","year":"2005","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1002\/14651858.CD012744-BIB0045|cit43","volume-title":"A Prospective Study of Bethanechol in the Salivary Glands Physiology in Patients Following Head and Neck Radiotherapy [Estudo Prospectivo do Uso do Betanecol na Fisiologia de Gl\u00e2ndulas Salivares em Pacientes Irradiados em Regi\u00e3o de Cabe\u00e7a e Pesco\u00e7o] [Diss","author":"Jaguar","year":"2010"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012744-BIB0043|cit44","first-page":"S252","article-title":"Double-blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in cancer patients","volume":"20","author":"Jaguar","year":"2012","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0044|cit45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2015.03.017","article-title":"Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients","volume":"115","author":"Jaguar","year":"2015","journal-title":"Radiotherapy and Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cncr.22020","article-title":"Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: a prospective randomized study in squamous cell head and neck cancer","volume":"107","author":"Jellema","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2334\/josnusd.51.565","article-title":"A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis","volume":"51","author":"Jham","year":"2009","journal-title":"Journal of Oral Science"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.oraloncology.2006.01.013","article-title":"A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer","volume":"43","author":"Jham","year":"2007","journal-title":"Oral Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0049|cit49","first-page":"65","article-title":"Pilocarpine in the prevention of postirradiation xerostomia","volume":"54","author":"Lajtman","year":"2000","journal-title":"Acta Medica Croatica"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.4317\/medoral.15.e732","article-title":"Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse","volume":"15","author":"Lanz\u00f3s","year":"2010","journal-title":"Medicina Oral, Patolog\u00eda Oral y Cirug\u00eda Bucal"},{"issue":"20","key":"10.1002\/14651858.CD012744-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","article-title":"Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study","volume":"29","author":"Le","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0052|cit52","first-page":"152","article-title":"Prevention of acute radiation-associated toxicity by traditional chinese medicine Tianwang Buxin mini-pills in patients with head and neck cancer","volume":"34","author":"Lin","year":"2014","journal-title":"Journal of Medical Sciences (Taipei, Taiwan)"},{"key":"10.1002\/14651858.CD012744-BIB0053|cit53","first-page":"399","article-title":"A pilot study to evaluate the effect of pilocarpine tablets on salivary flow and mucositis in head and neck cancer patients during radiotherapy","volume":"17","author":"Lozada-Nur","year":"1998","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"14 Suppl","key":"10.1002\/14651858.CD012744-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1200\/jco.2004.22.90140.5568","article-title":"The role of amifostine in prophylaxis of radiotherapy induced mucositis and xerostomia in head and neck cancer","volume":"22","author":"Patni","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0055|cit55","first-page":"1166","article-title":"Efficacy of amifostine on patients with head and neck squamous cell carcinomas undergoing radiation therapy and chemotherapy and clinical observation on its hematologic toxicity","volume":"17","author":"Peng","year":"2006","journal-title":"Journal of China Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0056|cit56","first-page":"1993","article-title":"Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands","volume":"34","author":"Pimentel","year":"2014","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD012744-BIB0057|cit57","first-page":"39","article-title":"Tulasi (Ocimum Sanctum) as radioprotector in head and neck cancer patients undergoing radiation therapy","volume":"32","author":"Reshma","year":"2012","journal-title":"Biomedicine"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0360-3016(99)00165-0","article-title":"The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients","volume":"45","author":"Rode","year":"1999","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0059|cit59","first-page":"195","article-title":"Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia","volume":"84","author":"Sangthawan","year":"2001","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD012744-BIB0060|cit60","first-page":"242","article-title":"Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia","volume":"7","author":"Sangthawan","year":"2002","journal-title":"Radiation Oncology Association of Thailand"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00066-003-1016-1","article-title":"Randomized phase III trial of postoperative radiochemotherapy +\/- amifostine in head and neck cancer. Is there evidence for radioprotection?","volume":"179","author":"Vacha","year":"2003","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1002\/14651858.CD012744-BIB0062|cit62","first-page":"18","article-title":"Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial","volume":"175 Suppl 4","author":"Vacha","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/1097-0142(19930301)71:5<1848::AID-CNCR2820710522>3.0.CO;2-F","article-title":"Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction","volume":"71","author":"Valdez","year":"1993","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012744-BIB0064|cit64","first-page":"87","article-title":"Oral complications of cancer therapies. Pretherapy interventions to modify salivary dysfunction","volume":"(9)","author":"Wolff","year":"1990","journal-title":"NCI Monographs"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1016\/S1359-6349(03)90935-9","article-title":"Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland dysfunction","volume":"1","author":"Veerasarn","year":"2003","journal-title":"European Journal of Cancer Supplements"},{"issue":"12","key":"10.1002\/14651858.CD012744-BIB0066|cit66","first-page":"2056","article-title":"Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function","volume":"89","author":"Veerasarn","year":"2006","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"11","key":"10.1002\/14651858.CD012744-BIB0067|cit67","first-page":"662","article-title":"Effects of traditional Chinese medicine on salivary glands in the patients with head and neck cancer during radiotherapy","volume":"18","author":"Wang","year":"1998","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0360-3016(02)02890-0","article-title":"A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head and neck cancer","volume":"54","author":"Warde","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"8","key":"10.1002\/14651858.CD012744-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/ijc.25200","article-title":"Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer","volume":"127","author":"Watanabe","year":"2010","journal-title":"International Journal of Cancer"},{"issue":"6 Suppl 19","key":"10.1002\/14651858.CD012744-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0093-7754(02)70016-X","article-title":"Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer","volume":"29","author":"Ann\u00e9","year":"2002","journal-title":"Seminars in Oncology"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD012744-BIB0071|cit71","first-page":"ix177","article-title":"Evaluation of pilocarpine for the prevention of radiation induced xerostomia in head and neck cancers","volume":"18","author":"Bagga","year":"2007","journal-title":"Annals of Oncology"},{"issue":"1-2","key":"10.1002\/14651858.CD012744-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0360-3016(78)90125-6","article-title":"Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer","volume":"4","author":"Bakowski","year":"1978","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0073|cit73","first-page":"227","article-title":"Pycnogenol may alleviate adverse effects in oncologic treatment","volume":"50","author":"Belcaro","year":"2008","journal-title":"Panminerva Medica"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02753843","article-title":"Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer","volume":"175","author":"Bohuslavizki","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012744-BIB0075|cit75","first-page":"6","article-title":"Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer","volume":"175","author":"Bohuslavizki","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"issue":"11","key":"10.1002\/14651858.CD012744-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1200\/JCO.1998.16.11.3542","article-title":"Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study","volume":"16","author":"Bohuslavizki","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/cbr.1999.14.337","article-title":"Salivary gland protection by S-2-(3-amino-propylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial","volume":"14","author":"Bohuslavizki","year":"1999","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"issue":"12","key":"10.1002\/14651858.CD012744-BIB0078|cit78","first-page":"A3","article-title":"Randomised double-blind trial of amifostine vs placebo for radiation-induced xerostomia in patients with head and neck cancer","volume":"77","author":"Borg","year":"2007","journal-title":"ANZ Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0360-3016(99)00532-5","article-title":"A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma","volume":"46","author":"Bourhis","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6 Suppl 19","key":"10.1002\/14651858.CD012744-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/sonc.2002.37350","article-title":"Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation","volume":"29","author":"Braaksma","year":"2002","journal-title":"Seminars in Oncology"},{"issue":"14","key":"10.1002\/14651858.CD012744-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.ejca.2005.05.012","article-title":"Costs of treatment intensification for head and neck cancer: concomitant chemoradiation randomised for radioprotection with amifostine","volume":"41","author":"Braaksma","year":"2005","journal-title":"European Journal of Cancer"},{"issue":"16 Suppl","key":"10.1002\/14651858.CD012744-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/jco.2005.23.16_suppl.5503","article-title":"Two phase III clinical studies of cevimeline for post-radiation xerostomia in patients with head and neck cancer","volume":"23","author":"Chambers","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5336\/medsci.2011-23100","article-title":"The effect of amifostine on acute and late radiation side effects in head and neck cancer patients","volume":"32","author":"Demiroz","year":"2012","journal-title":"Turkiye Klinikleri Journal of Medical Sciences"},{"issue":"8","key":"10.1002\/14651858.CD012744-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MNM.0b013e328362b1f2","article-title":"Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?","volume":"34","author":"Fallahi","year":"2013","journal-title":"Nuclear Medicine Communications"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0085|cit85","first-page":"146","article-title":"Protective effect of amifostine in irradiation mucositis of the oral cavity and dry mouth after nasapharyngeal carcinoma","volume":"13","author":"Fan","year":"2011","journal-title":"Military Medical Journal of Southeast China"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/02841869509093959","article-title":"Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study","volume":"34","author":"Franz\u00e9n","year":"1995","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0212-6982(04)72296-X","article-title":"Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow","volume":"23","author":"Fuertes Cabero","year":"2004","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear"},{"issue":"18 Suppl","key":"10.1002\/14651858.CD012744-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1200\/jco.2007.25.18_suppl.6088","article-title":"Effect of oral pilocarpine on xerostomia and quality of life in patients receiving curative radiotherapy for head and neck cancers","volume":"25","author":"Goyal","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"e95968","DOI":"10.1371\/journal.pone.0095968","article-title":"Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials","volume":"9","author":"Gu","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0360-3016(02)03750-1","article-title":"Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07)","volume":"54","author":"Johnson","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0091|cit91","first-page":"23","article-title":"A randomized trial of amifostine as radioprotector in the radiotherapy of head and neck cancer","volume":"9","author":"Karacetin","year":"2004","journal-title":"Journal of BUON"},{"issue":"11","key":"10.1002\/14651858.CD012744-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","article-title":"Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study","volume":"18","author":"Koukourakis","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.freeradbiomed.2010.10.153","article-title":"Ocimum Sanctum as a radioprotector in head and neck cancer patients undergoing radiation therapy","volume":"49 Suppl","author":"Kumarchandra","year":"2010","journal-title":"Free Radical Biology and Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012744-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1016\/j.ijrobp.2014.05.1700","article-title":"The use of xylitol for the prevention of xerostomia in patients receiving intensity modulated radiation therapy for head and neck cancers","volume":"90","author":"Manoor Maiya","year":"2014","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00006231-200106000-00008","article-title":"Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours","volume":"22","author":"Mateos","year":"2001","journal-title":"Nuclear Medicine Communications"},{"key":"10.1002\/14651858.CD012744-BIB0096|cit96","unstructured":"Mitine C Chaltin M Salembier C Merlo P Beauduin M Head and neck radiotherapy: does pilocarpine hydrochloride reduce radiation-induced xerostomia? Proceedings of the management of head and neck tumors: what are the challenges for the third millennium; 1999 Dec 3-4; Brussels (Belgium) European Laryngological Society 1999"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD012744-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1016\/j.ijrobp.2013.06.1234","article-title":"Randomized double-blind, placebo-controlled, multicenter phase 2 trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in locally-advanced squamous cell carcinoma of the head and neck","volume":"87","author":"Mix","year":"2013","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD012744-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1368-8375(02)00144-6","article-title":"Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection","volume":"39","author":"Nicolatou-Galitis","year":"2003","journal-title":"Oral Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0099|cit99","first-page":"234","article-title":"Can pilocarpine treatment during irradiation prevent salivary gland damage?","volume":"20","author":"Norberg-Spaak","year":"1996","journal-title":"Swedish Dental Journal"},{"key":"10.1002\/14651858.CD012744-BIB0100|cit100","first-page":"88","article-title":"Can pilocarpine treatment during irradiation prevent salivary gland damage","volume":"22","author":"Norberg-Spaak","year":"1997","journal-title":"Clinical Otolaryngology and Allied Sciences"},{"issue":"2B","key":"10.1002\/14651858.CD012744-BIB0102|cit101","first-page":"1557","article-title":"A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer","volume":"26","author":"Ny\u00e1r\u00e1dy","year":"2006","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD012744-BIB0101|cit102","first-page":"230","article-title":"Relieving symptoms of xerostomia with oral pilocarpine (Salagen) during irradiation in head-and-neck cancer","volume":"32 Suppl 1","author":"Ny\u00e1r\u00e1dy","year":"2004","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012744-BIB0103|cit103","first-page":"S246","article-title":"Effects of cold sterile normal saline (CSNS) mouth care in head and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT)","volume":"20","author":"Park","year":"2012","journal-title":"Supportive Care in Cancer"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD012744-BIB0104|cit104","first-page":"P174","article-title":"Protection of radiotherapy-induced xerostomia with vitamin E+C complex","volume":"147","author":"Park","year":"2012","journal-title":"Otolaryngology - Head and Neck Surgery"},{"key":"10.1002\/14651858.CD012744-BIB0105|cit105","first-page":"23","article-title":"Supportive use of amifostine in patients with head and neck tumours undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?","volume":"175 Suppl 4","author":"Peters","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1002\/14651858.CD012744-BIB0106|cit106","volume-title":"Effects of Traditional Chinese Medicine on Salivary Glands of Patients with Head and Neck Cancer During Radiotherapy [Dissertation]","author":"Qian","year":"2003"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012744-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1016\/S0167-8140(11)70993-8","article-title":"The effect of zilongjin(r) in patients with head and neck cancer needing radiotherapy with and without chemotherapy","volume":"99","author":"Resubal","year":"2011","journal-title":"Radiotherapy and Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hed.21682","article-title":"Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer","volume":"34","author":"Rieger","year":"2012","journal-title":"Head & Neck"},{"issue":"18","key":"10.1002\/14651858.CD012744-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1200\/JCO.2009.27.4449","article-title":"Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group","volume":"28","author":"Rischin","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"16 Suppl","key":"10.1002\/14651858.CD012744-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1200\/jco.2005.23.16_suppl.5502","article-title":"The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy","volume":"23","author":"Rudat","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012744-BIB0111|cit111","first-page":"27","article-title":"Amifostine - a radioprotector in locally advanced head and neck tumours","volume":"175 Suppl 4","author":"Sch\u00f6nek\u00e4s","year":"1999","journal-title":"Strahlentherapie und Onkologie"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ejca.2011.06.010","article-title":"Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study","volume":"48","author":"Sharma","year":"2012","journal-title":"European Journal of Cancer"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012744-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/S0959-8049(97)85526-8","article-title":"Preliminary results of a randomised study using WR-2721 in radiation therapy alone in patients with head and neck cancer","volume":"33","author":"Strnad","year":"1997","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00130404-200605000-00005","article-title":"Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer","volume":"12","author":"Su","year":"2006","journal-title":"Cancer Journal (Sudbury, Mass.)"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0360-3016(86)90388-3","article-title":"Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury","volume":"12","author":"Takahashi","year":"1986","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6 Suppl 18","key":"10.1002\/14651858.CD012744-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.seminoncol.2003.11.020","article-title":"Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary data","volume":"30","author":"Thorstad","year":"2003","journal-title":"Seminars in Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11282-005-0027-2","article-title":"Effectiveness of cepharanthin in decreasing interruptions during radiation therapy for oral cancer","volume":"21","author":"Uchiyama","year":"2005","journal-title":"Oral Radiology"},{"issue":"Abs Spec Issue","key":"10.1002\/14651858.CD012744-BIB0118|cit118","first-page":"375","article-title":"Pilocarpine effects on xerostomia associated with radiation therapy","volume":"72","author":"Zale","year":"1993","journal-title":"Journal of Dental Research"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0360-3016(97)85496-X","article-title":"Timing of pilocarpine treatment during head and neck radiotherapy: concomitant administration reduces xerostomia better than post-radiation pilocarpine","volume":"36 Suppl 1","author":"Zimmerman","year":"1996","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(96)00557-3","article-title":"Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia","volume":"37","author":"Zimmerman","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0121|cit121","first-page":"243","article-title":"Concomitant pilocarpine during head and neck irradiation reduces xerostomia","volume":"4","author":"Zimmerman","year":"1996","journal-title":"Supportive Care in Cancer"},{"issue":"4S","key":"10.1002\/14651858.CD012744-BIB0122|cit122","first-page":"86-7, 95","article-title":"Amifostine in prevention of radiation-induced xerostomia","volume":"30","author":"Yu","year":"2009","journal-title":"Journal of Sun Yat-Sen University (Medical Sciences)"},{"key":"10.1002\/14651858.CD012744-BIB0123|cit123","unstructured":"NCT02430298 Topical\/oral melatonin for preventing concurrent radiochemotherapy induced oral mucositis\/xerostomia cancer patients clinicaltrials.gov\/show\/NCT02430298"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/000348949410300208","article-title":"Influence on rabbit submandibular gland injury by stimulation or inhibition of gland function during irradiation. Histology and morphometry after 15 gray","volume":"103","author":"Ahlner","year":"1994","journal-title":"Annals of Otology, Rhinology, and Laryngology"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/srao.2003.50006","article-title":"Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy","volume":"13","author":"Andreassen","year":"2003","journal-title":"Seminars in Radiation Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/CNV-100000145","article-title":"Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany","volume":"19","author":"Bennett","year":"2001","journal-title":"Cancer Investigations"},{"issue":"7","key":"10.1002\/14651858.CD012744-BIB0127|cit127","first-page":"1237","article-title":"Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy","volume":"39","author":"Bohuslavizki","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD012744-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2016.03.012","article-title":"Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement","volume":"102","author":"Buglione","year":"2016","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"8","key":"10.1002\/14651858.CD012744-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001973.pub4","article-title":"Interventions for treating oral mucositis for patients with cancer receiving treatment","author":"Clarkson","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012744-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003782.pub3","article-title":"Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy","author":"Davies","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012744-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/00220345870660S107","article-title":"Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man","volume":"66 Spec No","author":"Dawes","year":"1987","journal-title":"Journal of Dental Research"},{"issue":"7109","key":"10.1002\/14651858.CD012744-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0030-4220(94)90320-4","article-title":"A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study","volume":"77","author":"Epstein","year":"1994","journal-title":"Oral Surgery, Oral Medicine, and Oral Pathology"},{"issue":"7454","key":"10.1002\/14651858.CD012744-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s005200050075","article-title":"Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment","volume":"5","author":"Guchelaar","year":"1997","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD012744-BIB0136|cit136","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0962280210392008","article-title":"Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study","volume":"21","author":"Kontopantelis","year":"2012","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD012744-BIB0138|cit138","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012744-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.oraloncology.2016.12.031","article-title":"Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis","volume":"66","author":"Mercadante","year":"2017","journal-title":"Oral Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012744-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/00220345920710070301","article-title":"Clinical criteria for the diagnosis of salivary gland hypofunction","volume":"71","author":"Navazesh","year":"1992","journal-title":"Journal of Dental Research"},{"issue":"2","key":"10.1002\/14651858.CD012744-BIB0141|cit141","first-page":"56","article-title":"Diagnosis and management of the dry mouth: Part 1","volume":"23","author":"Pankhurst","year":"1996","journal-title":"Dental Update"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tripleo.2003.07.010","article-title":"An update of the etiology and management of xerostomia","volume":"97","author":"Porter","year":"2004","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2003.10.005","article-title":"Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients","volume":"70","author":"Rades","year":"2004","journal-title":"Radiotherapy and Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012744-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/moe.2001.115984","article-title":"The influence of pilocarpine and biperiden on pH value and calcium, phosphate, and bicarbonate concentrations in saliva during and after radiotherapy for head and neck cancer","volume":"92","author":"Rode","year":"2001","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"issue":"S66","key":"10.1002\/14651858.CD012744-BIB0145|cit145","first-page":"e1","article-title":"Management of salivary hypofunction during and after radiotherapy","volume":"103 Suppl","author":"Shiboski","year":"2007","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"key":"10.1002\/14651858.CD012744-BIB0146|cit146","first-page":"43","article-title":"Xerostomia: diagnosis, management and clinical complications","volume-title":"Saliva and Oral Health","author":"Sreebny","year":"1996"},{"key":"10.1002\/14651858.CD012744-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0360-3016(86)90388-3","article-title":"Clinical study of the radioprotective effects of amifostine (TM-08310, WR-2721) on chronic radiation injury","volume":"12","author":"Takahashi","year":"1986","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD012744-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-199549010-00010","article-title":"Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia","volume":"49","author":"Wiseman","year":"1995","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD012744-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000978.pub5","article-title":"Interventions for preventing oral mucositis for patients with cancer receiving treatment","author":"Worthington","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(96)00557-3","article-title":"Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia","volume":"37","author":"Zimmerman","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD012744-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004940","article-title":"Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy","author":"Tavender","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012744-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004940.pub2","article-title":"Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy","author":"Tavender","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T06:33:36Z","timestamp":1705905216000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012744"}},"subtitle":[],"editor":[{"name":"Cochrane Oral Health Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":152,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012744","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]}}}